Three Value Stocks Estimated To Be Below Their Intrinsic Worth In May 2025
Over the last 7 days, the United States market has dropped 2.7%, yet it has risen by 9.1% over the past year, with earnings expected to grow by 14% per annum in the coming years. In this environment, identifying stocks that are estimated to be below their intrinsic worth can provide opportunities for investors seeking value amidst fluctuating market conditions.
Name
Current Price
Fair Value (Est)
Discount (Est)
Mid Penn Bancorp (NasdaqGM:MPB)
$26.65
$52.26
49%
Burke & Herbert Financial Services (NasdaqCM:BHRB)
$55.38
$108.55
49%
Super Group (SGHC) (NYSE:SGHC)
$8.41
$16.48
49%
UMH Properties (NYSE:UMH)
$16.47
$32.47
49.3%
Advanced Flower Capital (NasdaqGM:AFCG)
$4.72
$9.39
49.7%
Excelerate Energy (NYSE:EE)
$28.93
$57.38
49.6%
TXO Partners (NYSE:TXO)
$15.30
$29.92
48.9%
ZEEKR Intelligent Technology Holding (NYSE:ZK)
$29.17
$57.33
49.1%
FinWise Bancorp (NasdaqGM:FINW)
$14.445
$28.38
49.1%
Clearfield (NasdaqGM:CLFD)
$38.30
$74.77
48.8%
Click here to see the full list of 171 stocks from our Undervalued US Stocks Based On Cash Flows screener.
Let's review some notable picks from our screened stocks.
Overview: Lindblad Expeditions Holdings, Inc. offers marine expedition adventures and travel experiences globally, with a market cap of $557.47 million.
Operations: The company's revenue is divided into two main segments: Lindblad, generating $436.11 million, and Land Experiences, contributing $234.72 million.
Estimated Discount To Fair Value: 38.1%
Lindblad Expeditions Holdings is trading at US$10.19, significantly below its estimated fair value of US$16.45, indicating potential undervaluation based on cash flows. Recent earnings reports show improved financial performance with Q1 2025 sales at US$179.72 million and a net income of US$1.16 million, reversing a loss from the previous year. The company forecasts tour revenues between $700 million to $750 million for 2025 and has formed strategic alliances to expand European river cruising operations through 2028.
Upon reviewing our latest growth report, Lindblad Expeditions Holdings' projected financial performance appears quite optimistic.
Unlock comprehensive insights into our analysis of Lindblad Expeditions Holdings stock in this financial health report.
Overview: RADA Electronic Industries Ltd. is a defense technology company that develops, manufactures, markets, and sells defense electronics to air forces and companies globally, with a market cap of $490.92 million.
Operations: RADA Electronic Industries Ltd. generates revenue through the development, manufacturing, marketing, and sale of defense electronics to air forces and companies worldwide.
Estimated Discount To Fair Value: 36.7%
RADA Electronic Industries, priced at $9.87, is trading 36.7% below its estimated fair value of $15.58, highlighting potential undervaluation based on cash flows. The company's earnings are projected to grow significantly at 83.7% per year, outpacing the US market's growth rate of 15%. However, profit margins have decreased from 19.5% last year to 5.3%, which may be a concern for investors despite the expected revenue growth of 16.1% annually surpassing the market average.
The growth report we've compiled suggests that RADA Electronic Industries' future prospects could be on the up.
Dive into the specifics of RADA Electronic Industries here with our thorough financial health report.
Overview: West Bancorporation, Inc. is a financial holding company that offers community banking and trust services to individuals and small- to medium-sized businesses in the United States, with a market cap of approximately $327.30 million.
Operations: The company generates revenue primarily through its community banking segment, which accounted for $82.85 million.
Estimated Discount To Fair Value: 36.7%
West Bancorporation, trading at US$19.34, is priced 36.7% below its estimated fair value of US$30.55, suggesting it may be undervalued based on cash flows. The company's earnings grew by 18% last year and are expected to grow significantly over the next three years, surpassing the US market's growth rate. Recent results show net income increased to US$7.84 million from US$5.81 million a year ago, with a steady dividend of $0.25 per share declared for May 2025.
Our earnings growth report unveils the potential for significant increases in West Bancorporation's future results.
Click here and access our complete balance sheet health report to understand the dynamics of West Bancorporation.
Investigate our full lineup of 171 Undervalued US Stocks Based On Cash Flows right here.
Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqCM:LIND NasdaqCM:RADA and NasdaqGS:WTBA.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Koppers Announces Participation in Upcoming Investor Conferences
PITTSBURGH, June 5, 2025 /PRNewswire/ -- Koppers Holdings Inc. (NYSE: KOP), an integrated global provider of treated wood products, wood treatment chemicals and carbon compounds, today announced that the company will host meetings with the investment community as part of its participation in upcoming investor conferences as follows: Sidoti Small Cap Conference, which will be held virtually, on June 12, 2025. Singular Research Summer Solstice Conference, which will be held in New York City, on June 18, 2025. Koppers management will be represented by Bradley Pearce, Chief Accounting Officer, and Quynh McGuire, Vice President of Investor Relations. Presentation materials will be available on in the Investor Relations section of the company's website. About Koppers Koppers (NYSE: KOP) is an integrated global provider of essential treated wood products, wood preservation technologies and carbon compounds. Our team of 2,100 employees create, protect and preserve key elements of our global infrastructure – including railroad crossties, utility poles, outdoor wooden structures, and production feedstocks for steel, aluminum and construction materials, among others – applying decades of industry-leading expertise while constantly innovating to anticipate the needs of tomorrow. Together we are providing safe and sustainable solutions to enable rail transportation, keep power flowing, and create spaces of enjoyment for people everywhere. Protecting What Matters, Preserving The Future. Learn more at Inquiries from the media should be directed to Ms. Jessica Franklin Black at BlackJF@ or 412-227-2025. Inquiries from the investment community should be directed to Ms. Quynh McGuire at McGuireQT@ or 412-227-2049. For Information:Quynh McGuire, Vice President, Investor Relations 412 227 2049 McGuireQT@ View original content to download multimedia: SOURCE KOPPERS HOLDINGS INC. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
15 minutes ago
- Forbes
What's Behind Newmont Mining's 44% Surge?
CANADA - 2025/03/23: In this photo illustration, the Newmont Mining Corporation logo is seen ... More displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images) Newmont (NYSE:NEM)'s stock has experienced quite a bit of volatility this year. It began the year on a weak note, primarily impacted by declining gold prices and concerns regarding costs and production delays. However, things started to improve as gold prices surged—thanks to global uncertainty and increased purchases by central banks. Thus far in 2025, NEM has made a solid recovery, regaining a significant portion of its previous losses. Although it isn't breaking records, it's now in a more favorable position than it was at the beginning of the year, with a year-to-date gain of 44%. The movement in Newmont's stock price aligns with that of its peers, which include Wheaton Precious Metals (NYSE:WPM) that has risen 58% and Barrick Gold (NYSE: B) that has increased by 20% in the same timeframe. Newmont Corporation's stock has seen a recent increase due to a variety of factors. Gold prices have surged nearly 30% year-to-date, recently exceeding $3,500 per ounce. This surge is driven by global economic uncertainties, such as a U.S. trade conflict with China and political tensions surrounding Federal Reserve policy. As a major gold producer, Newmont directly benefits from higher gold prices, which enhance its revenues and profitability. Buy or Sell NEM. In 2023, Newmont finalized the acquisition of Newcrest Mining, developing an industry-leading portfolio with a long-term gold and copper production profile. The integration of Newcrest is anticipated to provide significant value to shareholders, with estimated pre-tax benefits of $500 million annually by the end of 2025. Furthermore, Newmont has been selling non-core assets, generating substantial proceeds to bolster its primary operations and financial standing. Additionally, for investors seeking potential returns with reduced volatility, the High Quality portfolio has comfortably outperformed the S&P 500, providing over 91% returns since its inception. Part of the increase observed in the last five months can be attributed to strong performance in the first quarter of 2025, propelled by soaring gold prices and strategic asset management. Revenue reached $5.01 billion, exceeding expectations by nearly $440 million. Adjusted EPS was recorded at $1.25, surpassing the consensus estimate of $0.71. Although Newmont has experienced significant revenue growth since 2021, its price-to-sales (PS) multiple has declined, dropping from 3.6x in 2021 to 2.2x in 2024. While the current PS is now 3.2x, there is potential for upside when comparing the current PS to historic levels: 3.6x at the close of 2020 and 2021. In Q1 2025, Newmont reported impressive financial results, driven by record-setting gold prices and effective portfolio optimization. The company announced adjusted EPS of $1.25, significantly exceeding analyst expectations, and revenue of $5.01 billion, which was supported by an average realized gold price of $2,944 per ounce. While gold production declined by 8% year-over-year to 1.5 million ounces, primarily due to divestitures of non-core assets, the company still achieved strong profitability, reporting $2.6 billion in adjusted EBITDA and $1.2 billion in free cash flow. Newmont successfully executed key divestitures—such as the Éléonore and Akyem mines—raising over $2.5 billion in proceeds and reducing its long-term debt by $1 billion. Additionally, it returned $1 billion to shareholders through dividends and buybacks. This strong performance reaffirmed confidence in Newmont's guidance for 2025 and supported the stock's recent upward trend. We currently estimate Newmont's valuation to be approximately $60 per share, about 8% above the current market price. Focusing on valuation in addition to growth is just one of the several strategies we utilize when constructing Trefis High Quality (HQ) Portfolio which, comprising a selection of 30 stocks, has shown a history of consistently outperforming the S&P 500 over the previous 4-year period. Why is that? As a group, HQ Portfolio stocks delivered superior returns with lower risk compared to the benchmark index; providing a smoother ride, as indicated in the HQ Portfolio performance metrics.
Yahoo
16 minutes ago
- Yahoo
High Growth Tech Stocks in Europe to Watch for Potential Expansion
The European market has shown resilience with the pan-European STOXX Europe 600 Index ending 0.65% higher, buoyed by easing trade tensions and slowing inflation in key economies, which may prompt further monetary easing by the European Central Bank. In this context of potential expansion and shifting economic policies, high-growth tech stocks become particularly intriguing for investors seeking opportunities that align with evolving market dynamics and technological advancements. Name Revenue Growth Earnings Growth Growth Rating Intellego Technologies 30.80% 45.66% ★★★★★★ Archos 21.07% 36.58% ★★★★★★ KebNi 21.51% 66.96% ★★★★★★ Pharma Mar 29.61% 44.92% ★★★★★★ Bonesupport Holding 29.14% 56.14% ★★★★★★ argenx 21.50% 26.61% ★★★★★★ Skolon 31.51% 99.52% ★★★★★★ Xbrane Biopharma 24.95% 56.77% ★★★★★★ Diamyd Medical 86.29% 93.04% ★★★★★★ Elliptic Laboratories 36.33% 78.99% ★★★★★★ Click here to see the full list of 228 stocks from our European High Growth Tech and AI Stocks screener. Here's a peek at a few of the choices from the screener. Simply Wall St Growth Rating: ★★★★★☆ Overview: Oryzon Genomics S.A. is a clinical-stage biopharmaceutical company focused on developing epigenetics-based therapeutics for cancer and CNS disorders, with a market cap of €226.34 million. Operations: Oryzon Genomics specializes in discovering and developing epigenetics-based therapeutics targeting cancer and CNS disorders. Oryzon Genomics, a trailblazer in epigenetic therapies, is making significant strides with an impressive 49.3% annual revenue growth forecast. Despite its current unprofitability, the company's strategic focus on R&D (13.26 million EUR allocated to the VANDAM project) underscores its commitment to addressing rare neurodevelopmental disorders and neuroendocrine tumors through precision medicine. The recent 15 million EUR grant for this project enhances Oryzon's potential in pioneering treatments that could revolutionize patient care in these underserved areas. Additionally, their involvement in high-profile clinical trials like the Phase I/II trial of iadademstat for small cell lung cancer further exemplifies their innovative approach within the biotech sector. With expected profitability and earnings growth of 50.17% per annum over the next three years, Oryzon is positioned to leverage its scientific advancements into commercial success. Click to explore a detailed breakdown of our findings in Oryzon Genomics' health report. Explore historical data to track Oryzon Genomics' performance over time in our Past section. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Atea ASA is a leading provider of IT infrastructure and related solutions for businesses and public sector organizations across the Nordic countries and Baltic regions, with a market capitalization of NOK16.73 billion. Operations: Atea ASA generates revenue primarily from its operations in Norway, Sweden, Denmark, Finland, and the Baltics. The highest revenue contribution comes from Sweden at NOK13.06 billion, followed by Norway at NOK9 billion. Group Shared Services account for NOK10.81 billion in costs. Atea's strategic emphasis on R&D, with a notable 13% of its revenue directed towards innovation, underpins its robust position in the European tech landscape. Despite a challenging year with earnings growth contracting by 8.8%, the company's revenue is still expected to outpace the Norwegian market, growing at 9.4% annually compared to the market's 2.6%. This resilience is further highlighted by Atea's recent dividend affirmation, committing NOK 786 million back to shareholders, showcasing confidence in its financial health and ongoing value creation strategies. Dive into the specifics of Atea here with our thorough health report. Examine Atea's past performance report to understand how it has performed in the past. Simply Wall St Growth Rating: ★★★★★☆ Overview: Paradox Interactive AB (publ) is a company that focuses on developing and publishing strategy and management games for PC and consoles across various global regions, with a market cap of approximately SEK20.90 billion. Operations: The company generates revenue primarily from its Computer Graphics segment, amounting to SEK2.18 billion. It operates in diverse regions including North and Latin America, Europe, the Middle East, Africa, and the Asia Pacific. Paradox Interactive, amidst a dynamic European tech landscape, continues to innovate and expand its gaming universe. The company's recent announcement of two new DLC packs for "Across the Obelisk" underscores its commitment to enhancing player experience and broadening content availability across multiple platforms. Strategic alliances like the one seen with Room 8 Group for "Crusader Kings III: Legacy of Persia" not only diversify Paradox's portfolio but also deepen its historical game narratives, reinforcing its niche in strategy games. Financially, Paradox is poised for growth with a revenue increase of 9.3% annually and an earnings forecast growing at 21.5% per year, complemented by a robust R&D investment strategy that ensures continuous innovation and competitiveness in the high-stakes gaming market. Click here and access our complete health analysis report to understand the dynamics of Paradox Interactive. Gain insights into Paradox Interactive's historical performance by reviewing our past performance report. Take a closer look at our European High Growth Tech and AI Stocks list of 228 companies by clicking here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BME:ORY OB:ATEA and OM:PDX. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
